Literature DB >> 11032976

Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia.

S Heckers1, T Curran, D Goff, S L Rauch, A J Fischman, N M Alpert, D L Schacter.   

Abstract

BACKGROUND: Many patients with schizophrenia demonstrate memory deficits. We studied patterns of brain activity during episodic recognition of new and previously seen three-dimensional objects.
METHODS: We used (15)O positron emission tomography to study regional cerebral blood flow in eight normal subjects and nine patients with schizophrenia during a visual object recognition task.
RESULTS: In comparison with control subjects, patients with schizophrenia showed less regional cerebral blood flow increases in the pulvinar region of the right thalamus and the right prefrontal cortex during the recognition of new objects and significantly greater left prefrontal cortex regional cerebral blood flow increases during the recognition of previously seen objects. Patients with schizophrenia exhibited alarm rates to new objects similar to those of control subjects, but significantly lower recognition rates for previously seen objects.
CONCLUSIONS: Schizophrenia is associated with attenuated right thalamic and right prefrontal activation during the recognition of novel visual stimuli and with increased left prefrontal cortical activation during impaired episodic recognition of previously seen visual stimuli. This study provides further evidence for abnormal thalamic and prefrontal cortex function in schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 11032976     DOI: 10.1016/s0006-3223(00)00919-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  34 in total

1.  An electrophysiological comparison of visual categorization and recognition memory.

Authors:  Tim Curran; James W Tanaka; Daniel M Weiskopf
Journal:  Cogn Affect Behav Neurosci       Date:  2002-03       Impact factor: 3.282

Review 2.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

Review 3.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk.

Authors:  Hengyi Cao; Sarah C McEwen; Yoonho Chung; Oliver Y Chén; Carrie E Bearden; Jean Addington; Bradley Goodyear; Kristin S Cadenhead; Heline Mirzakhanian; Barbara A Cornblatt; Ricardo E Carrión; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Aysenil Belger; Larry J Seidman; Heidi Thermenos; Ming T Tsuang; Theo G M van Erp; Elaine F Walker; Stephan Hamann; Alan Anticevic; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

5.  Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine.

Authors:  Indrani Poddar; Patrick M Callahan; Caterina M Hernandez; Xiangkun Yang; Michael G Bartlett; Alvin V Terry
Journal:  Biochem Pharmacol       Date:  2017-11-24       Impact factor: 5.858

6.  Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis.

Authors:  Michael Matthew Francis; Tom A Hummer; Jenifer L Vohs; Matthew G Yung; Emily Liffick; Nicole F Mehdiyoun; Alexander J Radnovich; Brenna C McDonald; Andrew J Saykin; Alan Breier
Journal:  Brain Imaging Behav       Date:  2016-03       Impact factor: 3.978

7.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

Review 8.  Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Authors:  Emilio Fernandez-Espejo; Maria-Paz Viveros; Luis Núñez; Bart A Ellenbroek; Fernando Rodriguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2009-07-24       Impact factor: 4.530

9.  Altered Thalamo-Cortical White Matter Connectivity: Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis.

Authors:  Kang Ik K Cho; Martha E Shenton; Marek Kubicki; Wi Hoon Jung; Tae Young Lee; Je-Yeon Yun; Sung Nyun Kim; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2015-11-23       Impact factor: 9.306

10.  Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.

Authors:  William Byne; Stella Dracheva; Benjamin Chin; James M Schmeidler; Kenneth L Davis; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2007-10-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.